Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thinking of adding here but I can't pull the trigger.
Probably will come out after earnings and either reiterate or offer a new rating.
I don't understand why RJ hasn't reiterated his buy on the stock at this price level unless he's expecting negative news.
man o man there just does not seem to be a floor on this thing! another OUCH for PROF on an otherwise up day
The one thing that really bothers me is I don't see any insider buying at these levels.
I also have my long position and hoping we get some positive news in a couple weeks. A strong 2Q and a positive outlook for the rest of the year will send us into the low to mid 20's. The fact that they have slowed down opening new sites gives me cause for concern. I also wish they would be more bullish with their PR's. Good luck to you!
Yeah, it picked up today, but even with a more than double of the 10 day average, it isn't much. With that said, there aren't a lot of shares so it is hard to really tell. With no real news, it could be good or bad. I kinda feel like we are in limbo a little. Ultimately, I think the product is top in the industry. Time will tell, but I still like the company. And, this company never really seems to pump anything. They are positive for sure, but don't pump every installation or things like that. I like that, but sometimes I wish they would be a little more bullish with their pr's. Just my opinion. I still have my full long position. Considering adding at some point. Bullish long term. Good luck to you.
Volume picking up, not sure if that's a good or bad sign.
TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- Profound Medical Corp. ( PROF
Loading...
Loading...
) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, will announce its first quarter 2021 financial results after market close on Wednesday, May 12, 2021.
Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.
First Quarter 2021 Results Conference Call Details:
Date: Wednesday, May 12, 2021
Time: 4:30 p.m. ET
Live Call: 1-833-710-1825 (Canada and the United States)
1-929-517-0404 (International)
Replay: 1-404-537-3406
Passcode: 4366998
The call will also be broadcast live and archived on the Company's website at www.profoundmedical.com under "Webcasts" in the Investors section.
would be nice ; 3-month chart just looking horrifical but maybe bottoming out
The company has been very quiet. Maybe we get something substantial in the next quarterly earnings call coming up in a couple weeks.
I feel like we are the forgotten child.
The combination of a bad market and no interest in the stock is hurting us now. Any positive news and we should pop above 22-23 very quickly.
another giant WTF today
let them walk it down, I will be buying. They can only hold it down for so long before Profound's excellent fundamentals kick in and they release some great news!
It almost seems like it’s a scare tactic. TripTrap may be on to something about hedge funds manipulating the stock. Hedge funds own 5% of the company, and they would have the power to walk this share price down.
shenanigans no doubt
weird AH numbers again - closed at 2050 AH showed 1890
Yep...exactly. Some real eye opening stuff and just want to get this info out there as much as possible and also educate myself.
Unbelievable the SEC, FBI, the press, etc. etc. has not cleaned house on this stuff...
Hundreds of smaller OTC companies have had much more devastating losses than PROF. Some people say it's a revenge from all the losses the MMs, hedge funds took on GameStop...
This should make for some interesting viewing over the weekend.
This could possibly explain the severe dip in PROF's price and hundreds of other stocks recently
"The Wall Street Conspiracy"
Educate yourself to what is going on around us. Yes it's a few years old but still extremely relevant. This video was riveting to me! One person commented "This is the most important documentary that nobody has seen." I agree...
Where the hell is the press, the SEC, congress etc etc...???
We are very fortunate that PROF is such a visible company in a hot sector with lots of money starting to roll in.
Extremely bullish long term on PROF in spite of the crap that goes on...
I think you're right. It needs to hold that level though around 200 day avg. It does bother me EDAP is doing so much better. EDAP is a competitor using HIFU and is more established. From my understanding our technology is better which should win in the end.
Daily Chart Observations
Because PROF is so rock solid fundamentally I usually don't give it much thought. I know though that the recent decline in PROF has not been fun for any of us longs.
I am sure most of you know that many stocks have taken a beating as of late for various reasons...not just PROF.
For the reasons stated on the chart below I do feel there is good reason to believe we have found a bottom over the last 2 days. Have a look to see why I feel that way and make your own conclusions.
These are just my opinions...anything could happen!!
Go PROF!!!
I’m confused what was going on with that $18.00 after hours PPS. It showed up on my iPhone stock app as such, but in my thinkorswim account I never saw the price move after hours. And then today PROF opened at $18.65, as if that after hours trading didn’t actually occur.
$18.00 in the after market. Folks, I think we have a real problem here!
less than average daily volume - feels like an oppy, like someone is trying to walk this down, but very scary
is this a buying opportunity or is there more to this drop?
WHAT THE HELL is going on here today!!!!!?????
Here is the link to the Journal of Urology article
https://www.auajournals.org/doi/pdf/10.1097/JU.0000000000001362
The Tulsa-Pro system was featured on the March 2021 cover of The Journal of Urology.
Contact PROF IR. I contacted them and I know at least one other who did to ask why they are not doing a PR for new installations. Seems like it would help the share price, certainly wouldn't hurt, and I can't think of any reason for them not to do this at least until the company is more mature. It is also free advertising for their service for potential customers.
You can email Stephen Kilmer in IR at skilmer@profoundmedical.com
Yesterday's price action created a nice little daily hook reversal - Lower low than the day before but closed higher than the close of the day before. It was done with a decent amount of volume.
As mentioned in my previous post we are in an area of technical support right now. 19-18 was an area of good resistance in the past. Now I am betting it will be an area of good support.
Will see if this puts an end to the recent overdone price decline.
I found out RJ analyst slightly lowered eps estimates after the last conf call but seemed to keep the price target unchanged. Several other analyst raised the target. Here is the link
https://www.marketbeat.com/instant-alerts/nasdaq-prof-analyst-earnings-estimates-2021-03/
only thing to think is that the price actually went up faster than it really should have last year. if a year ago you bought and 10 and i told you it would go to 20 you'd be thrilled - just try to forget it was at 28 in between - which was a $400mm valuation btw with little to no revenue
Hey gang...checking in.
I have no idea why we are doing what we are doing with PROF. Looks like the company is as solid as a rock still. Am I missing something?
I can tell you that there is solid technical support between where we are right now around 19 right down to 18. Solid solid support should come in at 18.40. Would be a good time to buy more me thinks!!
A lot of small cap companies have been under pressure as of late. We will get by this as long as you don't sell...
Just my opinion....
Keep in mind Hay that with a $25 share price that this company is valued at $500 million. There is a lot of speculation built into that. The company just needs to keep its head down and keep opening sites
Another new site opened. Like last time, no PR and the stock is down today. I don't know what day this was added to the website but I check most days.
https://tulsaprocedure.com/stanford-medicine-cancer-center/
looks like we may test 21 again
All good points, thank you for posting. I look forward to listening to the interviews.
That is what investor relations told me...yes.
The two interviews I posted a link to are worth watching. Some stuff in there that is new. Here's a short list:
Some private insurance companies paying for the procedure too...I heard this in the conf call but I thought they meant medicare advantage but they mean non medicare insurance. That is huge imo.
CEO says many urologists and patients nervous about surgery because of the risks of side effects of incontinence and ED so they often opt for the watch and wait strategy. He can see this change at some point as using Tulsa carries minimal risk. IMO this creates an expanding market.
CEO says they are introducing something called thermal boost which will allow for ablation of tissue that has expanded into the surrounding muscle for advanced cases.
CFO said one hospital tried to negotiate the price down and they said no and a couple months later the hospital came back and wanted to install a device anyway.
My understanding is once they show a new site it is up and running.
There are actually 2 new webcasts. Cowen on March 3 and Raymond James on Mar 2.
https://profoundmedical.com/investors/#presentations
Two new locations in the last two weeks. Seems like the pace is finally beginning to pick up. Even though this is another trial site it likely still requires the same if not even more effort to get up and going.
A new clinical trial site was added in the website. UCLA Health.
There is also a new webcast with Cowen that is very informative.
CEO talks about about how the radnet facilities and urologists think about it and how they need to talk to drs and assure them their role isn't being removed and they will still get revenue on pre and post treatment as they would without Tulsa.
I have been wondering if this could be used for pancreatic cancer which is notoriously hard to operate on. They usually even try to operate on pancreatic cancer due to the difficulty and the fact it is usually not diagnosed until advanced.
From the latest PR:
“The Company is in the early stages of exploring additional potential treatment markets for Sonalleve® where the technology has been shown to have clinical application, such as non-invasive ablation of abdominal cancers and hyperthermia for cancer therapy.”
The more uses a device has, the more likely a hospital will want to purchase that device.
Nice move today in a terrible market on almost 3 times the average volume.
I also watched the 40K block that took the share price from the just below 21.00 to over 22.00 dollars a share. We never dropped below 22.00 for the rest of the day.
Correct on the PR. I wish they would do a PR when they ink a new deal. I'm also wondering why the stock is down this morning. I'm wondering if it's because they wouldn't give any projections on how many sites they expect to have up and running this year. I understand it's because of the covid situation.
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1668
|
Created
|
04/22/19
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |